$COIN Buzzing Around The Message Boards - Might Be

Taking New Strides in Epilepsy Treatment Today, we’ve got SK Biopharmaceuticals banging on the FDA’s door with a pile of paperwork. They’re pushing for the green light on cenobamate to tackle primary generalized tonic-clonic (PGTC) seizures, plus expand its use to pediatric patients with the focal-onset seizure condition. Now, if you think it sounds like a big...

Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...

Rolling Out the Red Carpet for AI Innovators Worldwide Here's a call to all the boundary-pushing eggheads tinkering with artificial intelligence. The Globee® Awards is opening its doors again for the 3rd Annual AI showdown, inviting nominations from the creative minds conjuring up AI magic across the globe. This ain't your grandma's science fair; we're talking real-world...

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Let's talk straight here: when a private equity firm like Cordatus Capital jumps onto your train, it ain't just because they fancy a change of scenery or want some floor-scrubbing excitement. No, sir. This is a calculated play, and there's a chess game opening up over at Diamabrush. What's the Play? Cordatus has thrown its chips behind Diamabrush, a company that's made...

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Everyone's been dreaming about jackpot profits, huh? Well, for those holding onto Gildan Activewear Inc. (NYSE: GIL) shares, that bubble just popped. We're staring at a class-action lawsuit for securities fraud, accusing the company of cooking the books. Time for Wall Street's soap opera, folks. Understanding the Allegations Let's get to the grit. According to the lawsuit...

Understanding the Nuts and Bolts of Storefront Glass Replacement Picture your storefront beaten and battered, glass cracks spidering over once-pristine panes. Cue Matt Sears of Bentonville Glass Inc. ready to patch things up without turning your business into a disaster zone. The homegrown hero makes his debut in HelloNation's latest chat, offering the kind of advice you...

Big Bucks for Cyber Missteps When it rains, it pours—or in the case of ILC Dover, it’s a downpour of $13 million they’re forking over to settle a gnarly cybersecurity debacle. If you blinked, you might miss this hefty payout marking the biggest recovery under the Department of Justice’s Civil Cybersecurity Fraud program. So, what's the fuss about? Well, it's got...

Deadline Looms Large for AST SpaceMobile Investors Hot topic off the wire, folks: AST SpaceMobile's in hot water with a securities fraud class action lawsuit breathing down its neck. You got till November 13 to file for lead plaintiff status. If you picked up shares of NASDAQ:ASTS during the period from March 4, 2025, to July 15, 2026, now might just be the time to sit up...

Discover the Richness of Italian Wines at OperaWine 2026 OperaWine, known as the premier event of Vinitaly, is set to provide an unforgettable experience for wine enthusiasts and professionals. This highly anticipated event showcases Italy's finest wines, curated by Wine Spectator, a magazine renowned for its expertise in the wine industry. On the remarkable day of the...

Cognyte Software's Earnings Overview Cognyte Software (NASDAQ: CGNT) is on the verge of releasing its latest quarterly earnings report, and investor anticipation is palpable. With analysts estimating earnings per share (EPS) to be approximately $0.03, many are keen to see if the company meets or exceeds these expectations. What Investors Should Watch For For those holding...

Cassava Sciences, Inc. (NASDAQ: SAVA) took a hit back in 2024 when the U. S. Securities and Exchange Commission (SEC) wrapped up its investigation into the company’s past disclosures. The SEC alleged that Cassava had been negligent regarding its reporting on the 2020 Phase 2b clinical trial results for simufilam, a drug touted as a potential game-changer in...

AmpliTech Group Introduces Advanced Ultra Low Noise Amplifiers AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGW), a prominent designer and manufacturer specializing in signal processing components, proudly announces the successful delivery of prototype high-frequency Ultra Low Noise Amplifiers (ULNAs) to a major satellite network provider. These innovative amplifiers are...

OneDigital Strengthens Leadership with New Executive Appointments Bill Carew Named President; Camry Blaising Named Chief Operating Officer Based in Atlanta, OneDigital, a prominent insurance brokerage and HR consulting firm, has made significant executive appointments aimed at fostering growth and operational excellence. Bill Carew has been elevated to the position of...